Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamics of 08P2002F0 mydriatic eye drops in healthy volunteers
2024-517456-35-00Phase 2Completed
- Sponsor
- Unither Pharmaceuticals
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Mydriasert in Mydriasis (3 arms), sponsored by Unither Pharmaceuticals. Primary endpoint: Change in pupil diameter at 60 minutes versus baseline. Started Jun 2025; status: completed.
02
Drugs
Mydriasert
03
Conditions
Mydriasis
Beyond the preview
Go deeper on 2024-517456-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517456-35-00.